nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimetindene—CHRM2—epilepsy syndrome	0.374	1	CbGaD
Dimetindene—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0381	0.0707	CrCrCtD
Dimetindene—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0351	0.0651	CrCrCtD
Dimetindene—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0344	0.0638	CrCrCtD
Dimetindene—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.029	0.0537	CrCrCtD
Dimetindene—Trimipramine—Carbamazepine—epilepsy syndrome	0.0285	0.0529	CrCrCtD
Dimetindene—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0273	0.0506	CrCrCtD
Dimetindene—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0263	0.0487	CrCrCtD
Dimetindene—Imipramine—Carbamazepine—epilepsy syndrome	0.0262	0.0485	CrCrCtD
Dimetindene—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0251	0.0466	CrCrCtD
Dimetindene—Clomipramine—Clobazam—epilepsy syndrome	0.0246	0.0457	CrCrCtD
Dimetindene—Promethazine—Carbamazepine—epilepsy syndrome	0.0242	0.0449	CrCrCtD
Dimetindene—Chlorprothixene—Midazolam—epilepsy syndrome	0.0241	0.0447	CrCrCtD
Dimetindene—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0241	0.0447	CrCrCtD
Dimetindene—Alimemazine—Carbamazepine—epilepsy syndrome	0.0237	0.0441	CrCrCtD
Dimetindene—Clomipramine—Diazepam—epilepsy syndrome	0.0229	0.0425	CrCrCtD
Dimetindene—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0223	0.0413	CrCrCtD
Dimetindene—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0219	0.0406	CrCrCtD
Dimetindene—Chlorprothixene—Diazepam—epilepsy syndrome	0.0215	0.0398	CrCrCtD
Dimetindene—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0206	0.0383	CrCrCtD
Dimetindene—Promazine—Carbamazepine—epilepsy syndrome	0.0205	0.038	CrCrCtD
Dimetindene—Promazine—Oxcarbazepine—epilepsy syndrome	0.0189	0.035	CrCrCtD
Dimetindene—Disopyramide—KCND2—epilepsy syndrome	0.000471	0.0813	CrCbGaD
Dimetindene—Olopatadine—S100B—epilepsy syndrome	0.000387	0.0668	CrCbGaD
Dimetindene—Imipramine—KCND2—epilepsy syndrome	0.000176	0.0304	CrCbGaD
Dimetindene—Amitriptyline—KCND2—epilepsy syndrome	0.000175	0.0302	CrCbGaD
Dimetindene—Amitriptyline—KCNQ3—epilepsy syndrome	0.000163	0.0281	CrCbGaD
Dimetindene—Amitriptyline—KCNQ2—epilepsy syndrome	0.000163	0.0281	CrCbGaD
Dimetindene—Doxylamine—CHRM1—epilepsy syndrome	0.00016	0.0275	CrCbGaD
Dimetindene—Amitriptyline—NTRK2—epilepsy syndrome	0.000138	0.0239	CrCbGaD
Dimetindene—Orphenadrine—SCN9A—epilepsy syndrome	0.000135	0.0233	CrCbGaD
Dimetindene—Disopyramide—CHRM3—epilepsy syndrome	0.00013	0.0224	CrCbGaD
Dimetindene—Orphenadrine—SCN4A—epilepsy syndrome	0.000124	0.0214	CrCbGaD
Dimetindene—Disopyramide—CHRM1—epilepsy syndrome	0.000121	0.0209	CrCbGaD
Dimetindene—Disopyramide—CHRM2—epilepsy syndrome	9.87e-05	0.017	CrCbGaD
Dimetindene—Brompheniramine—CHRM3—epilepsy syndrome	9.63e-05	0.0166	CrCbGaD
Dimetindene—Orphenadrine—SCN1A—epilepsy syndrome	9.08e-05	0.0157	CrCbGaD
Dimetindene—Brompheniramine—CHRM1—epilepsy syndrome	8.99e-05	0.0155	CrCbGaD
Dimetindene—Brompheniramine—CHRM2—epilepsy syndrome	7.34e-05	0.0127	CrCbGaD
Dimetindene—Chlorprothixene—CHRM3—epilepsy syndrome	7.07e-05	0.0122	CrCbGaD
Dimetindene—Nortriptyline—CHRM3—epilepsy syndrome	6.94e-05	0.012	CrCbGaD
Dimetindene—Chlorprothixene—CHRM1—epilepsy syndrome	6.6e-05	0.0114	CrCbGaD
Dimetindene—Nortriptyline—CHRM1—epilepsy syndrome	6.47e-05	0.0112	CrCbGaD
Dimetindene—Promethazine—CHRM3—epilepsy syndrome	6.29e-05	0.0109	CrCbGaD
Dimetindene—Doxepin—CHRM3—epilepsy syndrome	6.23e-05	0.0107	CrCbGaD
Dimetindene—Mepyramine—CYP2D6—epilepsy syndrome	6.13e-05	0.0106	CrCbGaD
Dimetindene—Promethazine—CHRM1—epilepsy syndrome	5.87e-05	0.0101	CrCbGaD
Dimetindene—Doxepin—CHRM1—epilepsy syndrome	5.81e-05	0.01	CrCbGaD
Dimetindene—Tripelennamine—CYP2D6—epilepsy syndrome	5.67e-05	0.00978	CrCbGaD
Dimetindene—Amitriptyline—OPRD1—epilepsy syndrome	5.66e-05	0.00978	CrCbGaD
Dimetindene—Promazine—CHRM3—epilepsy syndrome	5.54e-05	0.00955	CrCbGaD
Dimetindene—Chlorprothixene—CHRM2—epilepsy syndrome	5.39e-05	0.00929	CrCbGaD
Dimetindene—Nortriptyline—CHRM2—epilepsy syndrome	5.29e-05	0.00912	CrCbGaD
Dimetindene—Carbinoxamine—CYP2C19—epilepsy syndrome	5.23e-05	0.00902	CrCbGaD
Dimetindene—Promazine—CHRM1—epilepsy syndrome	5.16e-05	0.00891	CrCbGaD
Dimetindene—Cyclobenzaprine—HTR2A—epilepsy syndrome	5.15e-05	0.00889	CrCbGaD
Dimetindene—Diphenhydramine—CHRM2—epilepsy syndrome	4.89e-05	0.00843	CrCbGaD
Dimetindene—Imipramine—CHRM3—epilepsy syndrome	4.85e-05	0.00836	CrCbGaD
Dimetindene—Amitriptyline—CHRM3—epilepsy syndrome	4.82e-05	0.00831	CrCbGaD
Dimetindene—Promethazine—CHRM2—epilepsy syndrome	4.79e-05	0.00827	CrCbGaD
Dimetindene—Doxepin—CHRM2—epilepsy syndrome	4.74e-05	0.00818	CrCbGaD
Dimetindene—Cyclobenzaprine—CYP2D6—epilepsy syndrome	4.71e-05	0.00813	CrCbGaD
Dimetindene—Chlorphenamine—SLC6A4—epilepsy syndrome	4.69e-05	0.00809	CrCbGaD
Dimetindene—Orphenadrine—CHRM2—epilepsy syndrome	4.62e-05	0.00798	CrCbGaD
Dimetindene—Clomipramine—ADRA2A—epilepsy syndrome	4.62e-05	0.00797	CrCbGaD
Dimetindene—Brompheniramine—CYP2C19—epilepsy syndrome	4.53e-05	0.00781	CrCbGaD
Dimetindene—Imipramine—CHRM1—epilepsy syndrome	4.52e-05	0.0078	CrCbGaD
Dimetindene—Amitriptyline—CHRM1—epilepsy syndrome	4.49e-05	0.00775	CrCbGaD
Dimetindene—Amitriptyline—OPRM1—epilepsy syndrome	4.33e-05	0.00748	CrCbGaD
Dimetindene—Trimipramine—ADRA2A—epilepsy syndrome	4.25e-05	0.00733	CrCbGaD
Dimetindene—Promazine—CHRM2—epilepsy syndrome	4.22e-05	0.00727	CrCbGaD
Dimetindene—Doxepin—ADRA2A—epilepsy syndrome	4.05e-05	0.00699	CrCbGaD
Dimetindene—Carbinoxamine—CYP2D6—epilepsy syndrome	3.88e-05	0.00669	CrCbGaD
Dimetindene—Imipramine—CHRM2—epilepsy syndrome	3.69e-05	0.00637	CrCbGaD
Dimetindene—Imipramine—HTR7—epilepsy syndrome	3.67e-05	0.00634	CrCbGaD
Dimetindene—Amitriptyline—CHRM2—epilepsy syndrome	3.67e-05	0.00633	CrCbGaD
Dimetindene—Amitriptyline—HTR7—epilepsy syndrome	3.65e-05	0.0063	CrCbGaD
Dimetindene—Promazine—ADRA2A—epilepsy syndrome	3.6e-05	0.00621	CrCbGaD
Dimetindene—Clomipramine—SLC6A4—epilepsy syndrome	3.52e-05	0.00608	CrCbGaD
Dimetindene—Nortriptyline—SLC6A4—epilepsy syndrome	3.44e-05	0.00594	CrCbGaD
Dimetindene—Brompheniramine—CYP2D6—epilepsy syndrome	3.36e-05	0.00579	CrCbGaD
Dimetindene—Clomipramine—CYP2C19—epilepsy syndrome	3.34e-05	0.00576	CrCbGaD
Dimetindene—Chlorphenamine—CYP2D6—epilepsy syndrome	3.3e-05	0.00569	CrCbGaD
Dimetindene—Nortriptyline—CYP2C19—epilepsy syndrome	3.26e-05	0.00563	CrCbGaD
Dimetindene—Trimipramine—SLC6A4—epilepsy syndrome	3.24e-05	0.00559	CrCbGaD
Dimetindene—Amitriptyline—ADRA2A—epilepsy syndrome	3.13e-05	0.0054	CrCbGaD
Dimetindene—Doxepin—SLC6A4—epilepsy syndrome	3.09e-05	0.00533	CrCbGaD
Dimetindene—Trimipramine—CYP2C19—epilepsy syndrome	3.07e-05	0.0053	CrCbGaD
Dimetindene—Diphenhydramine—CYP2C19—epilepsy syndrome	3.02e-05	0.0052	CrCbGaD
Dimetindene—Doxepin—CYP2C19—epilepsy syndrome	2.93e-05	0.00505	CrCbGaD
Dimetindene—Clomipramine—HTR2A—epilepsy syndrome	2.71e-05	0.00467	CrCbGaD
Dimetindene—Chlorprothixene—HTR2A—epilepsy syndrome	2.69e-05	0.00465	CrCbGaD
Dimetindene—Nortriptyline—HTR2A—epilepsy syndrome	2.64e-05	0.00456	CrCbGaD
Dimetindene—Promazine—CYP2C19—epilepsy syndrome	2.6e-05	0.00449	CrCbGaD
Dimetindene—Trimipramine—HTR2A—epilepsy syndrome	2.49e-05	0.0043	CrCbGaD
Dimetindene—Clomipramine—CYP2D6—epilepsy syndrome	2.48e-05	0.00427	CrCbGaD
Dimetindene—Nortriptyline—CYP2D6—epilepsy syndrome	2.42e-05	0.00417	CrCbGaD
Dimetindene—Imipramine—SLC6A4—epilepsy syndrome	2.4e-05	0.00415	CrCbGaD
Dimetindene—Promethazine—HTR2A—epilepsy syndrome	2.4e-05	0.00414	CrCbGaD
Dimetindene—Amitriptyline—SLC6A4—epilepsy syndrome	2.39e-05	0.00412	CrCbGaD
Dimetindene—Doxepin—HTR2A—epilepsy syndrome	2.37e-05	0.0041	CrCbGaD
Dimetindene—Imipramine—CYP2C19—epilepsy syndrome	2.28e-05	0.00393	CrCbGaD
Dimetindene—Trimipramine—CYP2D6—epilepsy syndrome	2.28e-05	0.00393	CrCbGaD
Dimetindene—Amitriptyline—CYP2C19—epilepsy syndrome	2.26e-05	0.00391	CrCbGaD
Dimetindene—Diphenhydramine—CYP2D6—epilepsy syndrome	2.24e-05	0.00386	CrCbGaD
Dimetindene—Promethazine—CYP2D6—epilepsy syndrome	2.19e-05	0.00378	CrCbGaD
Dimetindene—Doxepin—CYP2D6—epilepsy syndrome	2.17e-05	0.00374	CrCbGaD
Dimetindene—Promazine—HTR2A—epilepsy syndrome	2.11e-05	0.00364	CrCbGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.86e-05	0.000229	CbGpPWpGaD
Dimetindene—Clomipramine—ALB—epilepsy syndrome	1.85e-05	0.0032	CrCbGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.85e-05	0.000228	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.85e-05	0.000228	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.85e-05	0.000228	CbGpPWpGaD
Dimetindene—Imipramine—HTR2A—epilepsy syndrome	1.85e-05	0.00319	CrCbGaD
Dimetindene—Amitriptyline—HTR2A—epilepsy syndrome	1.84e-05	0.00317	CrCbGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL3—epilepsy syndrome	1.83e-05	0.000226	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL2—epilepsy syndrome	1.83e-05	0.000226	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—OXT—epilepsy syndrome	1.83e-05	0.000226	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CRH—epilepsy syndrome	1.83e-05	0.000226	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR2—epilepsy syndrome	1.82e-05	0.000225	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—SST—epilepsy syndrome	1.82e-05	0.000225	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.82e-05	0.000225	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.81e-05	0.000224	CbGpPWpGaD
Dimetindene—Nortriptyline—ALB—epilepsy syndrome	1.81e-05	0.00312	CrCbGaD
Dimetindene—CHRM2—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR9—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SSTR1—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR8—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NPY2R—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.78e-05	0.00022	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.78e-05	0.000219	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.78e-05	0.000219	CbGpPWpGaD
Dimetindene—Clomipramine—ABCB1—epilepsy syndrome	1.77e-05	0.00305	CrCbGaD
Dimetindene—Chlorprothixene—ABCB1—epilepsy syndrome	1.76e-05	0.00304	CrCbGaD
Dimetindene—CHRM2—Signaling Pathways—GRM3—epilepsy syndrome	1.75e-05	0.000216	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRM4—epilepsy syndrome	1.75e-05	0.000216	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.74e-05	0.000215	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.74e-05	0.000215	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.74e-05	0.000215	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.74e-05	0.000215	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SSTR2—epilepsy syndrome	1.72e-05	0.000212	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—DUSP4—epilepsy syndrome	1.72e-05	0.000212	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.71e-05	0.000211	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.71e-05	0.000211	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.71e-05	0.000211	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.7e-05	0.00021	CbGpPWpGaD
Dimetindene—Imipramine—CYP2D6—epilepsy syndrome	1.69e-05	0.00291	CrCbGaD
Dimetindene—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.68e-05	0.000208	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.68e-05	0.000208	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.68e-05	0.000207	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.68e-05	0.000207	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.68e-05	0.000207	CbGpPWpGaD
Dimetindene—Amitriptyline—CYP2D6—epilepsy syndrome	1.68e-05	0.0029	CrCbGaD
Dimetindene—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.67e-05	0.000207	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.67e-05	0.000206	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	1.66e-05	0.000205	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	1.66e-05	0.000205	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.65e-05	0.000204	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.64e-05	0.000203	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.64e-05	0.000202	CbGpPWpGaD
Dimetindene—Trimipramine—ABCB1—epilepsy syndrome	1.63e-05	0.00281	CrCbGaD
Dimetindene—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.62e-05	0.0002	CbGpPWpGaD
Dimetindene—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.61e-05	0.000199	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.61e-05	0.000198	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.61e-05	0.000198	CbGpPWpGaD
Dimetindene—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	1.59e-05	0.000196	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.59e-05	0.000196	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	1.58e-05	0.000195	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	1.58e-05	0.000195	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.58e-05	0.000195	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.58e-05	0.000195	CbGpPWpGaD
Dimetindene—Promethazine—ABCB1—epilepsy syndrome	1.57e-05	0.0027	CrCbGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	1.56e-05	0.000193	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.55e-05	0.000192	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	1.55e-05	0.000192	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.55e-05	0.000191	CbGpPWpGaD
Dimetindene—Doxepin—ABCB1—epilepsy syndrome	1.55e-05	0.00267	CrCbGaD
Dimetindene—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.54e-05	0.000191	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.54e-05	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.54e-05	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.54e-05	0.00019	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.54e-05	0.00019	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	1.53e-05	0.000188	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.52e-05	0.000188	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	1.51e-05	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	1.51e-05	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	1.51e-05	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	1.51e-05	0.000187	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.51e-05	0.000187	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	1.49e-05	0.000184	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.47e-05	0.000181	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.45e-05	0.000179	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.44e-05	0.000178	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.43e-05	0.000177	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.43e-05	0.000177	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.43e-05	0.000177	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.42e-05	0.000176	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	1.42e-05	0.000176	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	1.42e-05	0.000176	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	1.42e-05	0.000175	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	1.41e-05	0.000174	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	1.41e-05	0.000174	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	1.41e-05	0.000174	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.4e-05	0.000173	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.38e-05	0.00017	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.37e-05	0.00017	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.35e-05	0.000167	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.35e-05	0.000166	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.35e-05	0.000166	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.35e-05	0.000166	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.32e-05	0.000164	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.32e-05	0.000164	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.31e-05	0.000162	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.31e-05	0.000162	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.29e-05	0.00016	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.29e-05	0.000159	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	1.27e-05	0.000157	CbGpPWpGaD
Dimetindene—Amitriptyline—ALB—epilepsy syndrome	1.26e-05	0.00217	CrCbGaD
Dimetindene—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	1.26e-05	0.000155	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.25e-05	0.000155	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	1.24e-05	0.000153	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.23e-05	0.000153	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.22e-05	0.00015	CbGpPWpGaD
Dimetindene—Imipramine—ABCB1—epilepsy syndrome	1.21e-05	0.00208	CrCbGaD
Dimetindene—Amitriptyline—ABCB1—epilepsy syndrome	1.2e-05	0.00207	CrCbGaD
Dimetindene—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.19e-05	0.000147	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.17e-05	0.000145	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	1.17e-05	0.000144	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.17e-05	0.000144	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.15e-05	0.000142	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.15e-05	0.000142	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NPY—epilepsy syndrome	1.14e-05	0.00014	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.14e-05	0.00014	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.12e-05	0.000138	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.12e-05	0.000138	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	1.11e-05	0.000137	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—OXT—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CRH—epilepsy syndrome	1.1e-05	0.000136	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.09e-05	0.000135	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	1.08e-05	0.000134	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.08e-05	0.000133	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.06e-05	0.000132	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.06e-05	0.000131	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.02e-05	0.000126	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.01e-05	0.000124	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1e-05	0.000124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1e-05	0.000124	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1e-05	0.000124	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SST—epilepsy syndrome	9.92e-06	0.000123	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	9.92e-06	0.000123	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	9.92e-06	0.000123	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	9.89e-06	0.000122	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	9.83e-06	0.000122	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	9.76e-06	0.000121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	9.76e-06	0.000121	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SST—epilepsy syndrome	9.76e-06	0.000121	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.71e-06	0.00012	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	9.68e-06	0.00012	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	9.67e-06	0.000119	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.55e-06	0.000118	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	9.51e-06	0.000118	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	9.33e-06	0.000115	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	9.33e-06	0.000115	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	9.31e-06	0.000115	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	9.29e-06	0.000115	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	9.25e-06	0.000114	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	9.18e-06	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	9.18e-06	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	9.16e-06	0.000113	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	9.16e-06	0.000113	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	9.16e-06	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	9.14e-06	0.000113	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	9.12e-06	0.000113	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	9.1e-06	0.000112	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	9.01e-06	0.000111	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	9.01e-06	0.000111	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	8.98e-06	0.000111	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	8.93e-06	0.00011	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	8.79e-06	0.000109	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	8.67e-06	0.000107	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	8.53e-06	0.000105	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	8.51e-06	0.000105	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	8.46e-06	0.000105	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	8.38e-06	0.000103	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	8.32e-06	0.000103	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	8.31e-06	0.000103	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	8.28e-06	0.000102	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	8.18e-06	0.000101	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	8.14e-06	0.000101	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—S100B—epilepsy syndrome	7.86e-06	9.71e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	7.79e-06	9.62e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	7.77e-06	9.6e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	7.74e-06	9.56e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	7.66e-06	9.46e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	7.64e-06	9.44e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AVP—epilepsy syndrome	7.52e-06	9.29e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	7.4e-06	9.14e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HES1—epilepsy syndrome	7.11e-06	8.78e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	7e-06	8.64e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FYN—epilepsy syndrome	6.91e-06	8.54e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	6.89e-06	8.51e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	6.88e-06	8.5e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.8e-06	8.41e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.78e-06	8.38e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.77e-06	8.36e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.65e-06	8.21e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—NGF—epilepsy syndrome	6.57e-06	8.12e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.54e-06	8.08e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	6.47e-06	7.99e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	6.39e-06	7.9e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	6.29e-06	7.77e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	6.26e-06	7.73e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	6.16e-06	7.61e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	5.94e-06	7.34e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AGT—epilepsy syndrome	5.94e-06	7.33e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	5.85e-06	7.23e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	5.84e-06	7.22e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—APOE—epilepsy syndrome	5.82e-06	7.19e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.72e-06	7.07e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—KDR—epilepsy syndrome	5.7e-06	7.04e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.61e-06	6.93e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	5.49e-06	6.78e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	5.46e-06	6.75e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.4e-06	6.67e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.38e-06	6.64e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—POMC—epilepsy syndrome	5e-06	6.17e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.92e-06	6.07e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	4.89e-06	6.04e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.81e-06	5.94e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	4.42e-06	5.46e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.35e-06	5.37e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.1e-06	5.07e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.04e-06	4.99e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	4.02e-06	4.97e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.96e-06	4.89e-05	CbGpPWpGaD
Dimetindene—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.73e-06	4.61e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.7e-06	4.57e-05	CbGpPWpGaD
Dimetindene—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.67e-06	4.54e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.64e-06	4.5e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—JUN—epilepsy syndrome	3.59e-06	4.44e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.54e-06	4.37e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	3.5e-06	4.32e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.44e-06	4.25e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	3.39e-06	4.19e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.34e-06	4.12e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.22e-06	3.98e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.17e-06	3.92e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.14e-06	3.88e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.09e-06	3.82e-05	CbGpPWpGaD
Dimetindene—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2e-06	2.47e-05	CbGpPWpGaD
Dimetindene—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.97e-06	2.44e-05	CbGpPWpGaD
